DEPO-PROVERA Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Depo-provera, and what generic alternatives are available?
Depo-provera is a drug marketed by Pfizer and is included in two NDAs.
The generic ingredient in DEPO-PROVERA is medroxyprogesterone acetate. There are twenty drug master file entries for this compound. Twenty-four suppliers are listed for this compound. Additional details are available on the medroxyprogesterone acetate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Depo-provera
A generic version of DEPO-PROVERA was approved as medroxyprogesterone acetate by BARR on August 9th, 1996.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for DEPO-PROVERA?
- What are the global sales for DEPO-PROVERA?
- What is Average Wholesale Price for DEPO-PROVERA?
Summary for DEPO-PROVERA
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 2 |
| Finished Product Suppliers / Packagers: | 3 |
| Raw Ingredient (Bulk) Api Vendors: | 78 |
| Clinical Trials: | 59 |
| Patent Applications: | 4,237 |
| Drug Prices: | Drug price information for DEPO-PROVERA |
| What excipients (inactive ingredients) are in DEPO-PROVERA? | DEPO-PROVERA excipients list |
| DailyMed Link: | DEPO-PROVERA at DailyMed |
See drug prices for DEPO-PROVERA
Recent Clinical Trials for DEPO-PROVERA
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Oregon Health and Science University | Early Phase 1 |
| Canadian Institutes of Health Research (CIHR) | Phase 4 |
| Canadian Cancer Society (CCS) | Phase 4 |
Pharmacology for DEPO-PROVERA
| Drug Class | Progestin |
US Patents and Regulatory Information for DEPO-PROVERA
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pfizer | DEPO-PROVERA | medroxyprogesterone acetate | INJECTABLE;INJECTION | 012541-002 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Pfizer | DEPO-PROVERA | medroxyprogesterone acetate | INJECTABLE;INJECTION | 020246-001 | Oct 29, 1992 | AB | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Pfizer | DEPO-PROVERA | medroxyprogesterone acetate | INJECTABLE;INJECTION | 012541-003 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for DEPO-PROVERA
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Pfizer | DEPO-PROVERA | medroxyprogesterone acetate | INJECTABLE;INJECTION | 012541-002 | Approved Prior to Jan 1, 1982 | ⤷ Sign Up | ⤷ Sign Up |
| Pfizer | DEPO-PROVERA | medroxyprogesterone acetate | INJECTABLE;INJECTION | 012541-003 | Approved Prior to Jan 1, 1982 | ⤷ Sign Up | ⤷ Sign Up |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
